Diabetes diet

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• General Dietary Guidelines...
• Major Food Components
• Weight Control for Type 2 D...
• Heart-Healthy Diets
• Diabetic Exchange Lists
• Exercise
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Lifestyle Changes Essential for People at Risk for Diabetes Lifestyle interventions that include weight loss, dietary changes, and increased physical activity can definitely help prevent or delay the progression to diabetes among at-risk people, suggest several recent studies. Weight loss through diet and exercise is especially important for overweight people with pre-diabetes. Grain Fiber Important for Diabetes Prevention Eating whole-grain, fiber-rich, cereal foods may help reduce the risk of developing type 2 diabetes, indicates a 2007 study in the Archives of Internal Medicine. - 5 Comments

Peptic ulcers

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Symptoms
• Complications
• Risk Factors
• Diagnosis
• Treatment
• Treatment for NSAID-Induced...
• Medications
• Treatment for Bleeding Ulce...
• Lifestyle Changes
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Risk with cardiovascular medications While nonsteroidal anti-inflammatory drugs are the major medications responsible for causing peptic ulcers, drugs taken for cardiovascular disease and its risk factors may also cause ulcers. Recent studies have found an association between increased risk of ulcer and the following drugs:

• Spironolactone, a common diuretic used in heart failure
• Niacin, a drug used to lower "bad" cholesterol and raise "good" cholesterol
• Vitamin K antagonists, commonly prescribed anticoagulants
• Dipyridamole, a drug for secondary stroke prevention
• Low-dose aspirin, prescribed for both heart attack and stroke prevention

Risk of peptic ulcer increases dramatically when these drugs are used in combination. Considering the millions of people who take these medications to prevent a life-threatening cardiovascular event, their impact on peptic ulcer development could be monumental. - 0 Comments

Lactobacillus acidophilus

Oct 08, 2008 - Overview

• Overview
• Uses
• Dietary Sources
• Available Forms
• How to Take It
• Precautions
• Possible Interactions
• Supporting Research

HEALTH GUIDE REFERENCE FROM A.D.A.M Overview Lactobacillus acidophilus (L. acidophilus) is the most commonly used probiotic, or "friendly," bacteria. Such healthy bacteria inhabit the intestines and vagina and protect against the entrance and growth of "bad" organisms that can cause disease. - 0 Comments

Migraine headache

Oct 08, 2008 - Overview

• Signs and Symptoms
• Causes
• Risk Factors
• Diagnosis
• Treatment Approach
• Other Considerations
• Supporting Research

HEALTH GUIDE REFERENCE FROM A.D.A.M Migraines are severely painful, recurrent headaches that are sometimes accompanied by other symptoms such as visual disturbances (aura) or nausea. There are two types of migraine – migraine with aura (formerly called common migraines) and migraine without aura (formerly called classic migraines). If you have a migraine with aura, you may experience a visual disturbance (like seeing stars or zigzag lines or a temporary blind spot) about 30 minutes before the headache starts. - 0 Comments

Vitamins

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Carotenoids
• Phytochemicals
• Healthy Foods
• Dietary Health Benefits
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Cancer Growing evidence suggests that vitamins and micronutrients, especially from foods, may play important roles in the prevention or treatment of certain cancers:

• One study found that the risk of prostate cancer risk dropped as consumption of vegetables high in vitamin C, such as broccoli and bell peppers, rose.
• A diet high in cruciferous vegetables has been found to reduce the risk of kidney cancer; low consumption of cruciferous vegetables increases the risk.

On the other hand, high amounts of folic acid (a B vitamin) may be associated with colorectal cancer, and beta-carotene supplements are associated with increased lung cancer risk in smokers and people exposed to asbestos. Macular Degeneration In 2007, the National Eye Institute recommended that people with intermediate or advanced macular degeneration in one eye take a vitamin formula shown to reduce the risk of macular degeneration in the other eye by 25%. The formula contains vitamin C, vitamin E, beta-carotene, and zinc. - 0 Comments

Bone cancer

Oct 08, 2008 - Overview

• Signs and Symptoms
• Who's Most At Risk?
• What to Expect at Your Provider's Office
• Treatment Options
• Prognosis/Possible Complications
• Following Up
• Supporting Research

HEALTH GUIDE REFERENCE FROM A.D.A.M Bone cancers are rare forms of cancer that can affect any bone in the body. Two types of bone cancer are multiple myeloma and bone sarcomas. Bone cancers can also happen when tumors that start in other organs, such as breasts, lung, and prostate, metastasize (spread) to the bone. - 0 Comments

Ulcerative colitis

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Symptoms
• Complications
• Risk Factors
• Diagnosis
• Dietary Factors
• Symptom Management
• Medications
• Surgery
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Drug Approval In 2007, the FDA approved LIALDA, the first once-daily mesalamine pill for treating mild-to-moderate ulcerative colitis. Other types of mesalamine need to be taken several times a day. Genetic Research Scientists have made an important discovery by identifying a gene associated with inflammatory bowel disease. - 0 Comments

Crohn's disease

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Symptoms
• Complications
• Risk Factors
• Diagnosis
• Dietary Factors
• Symptom Management
• Medications
• Surgery
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Biologic Drugs

• In February 2007, the FDA approved adalimumab (Humira) for treatment of adult patients with moderate-to-severe Crohn’s disease. Adalimumab and infliximab (Remicade) are now the two biologic drugs approved for Crohn’s disease. Infliximab is approved for treating both adults and children.
• As of August 2007, the FDA was considering approving natalizumab (Tysabri) for moderate-to-severe Crohn’s disease in patients who have not responded to, or cannot tolerate, other therapies. - 0 Comments
  Read More ›